Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

746 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Catalytic photooxygenation degrades brain Aβ in vivo.
Nagashima N, Ozawa S, Furuta M, Oi M, Hori Y, Tomita T, Sohma Y, Kanai M. Nagashima N, et al. Among authors: furuta m. Sci Adv. 2021 Mar 24;7(13):eabc9750. doi: 10.1126/sciadv.abc9750. Print 2021 Mar. Sci Adv. 2021. PMID: 33762329 Free PMC article.
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.
Komori A, Hironaka S, Kadowaki S, Mitani S, Furuta M, Kawakami T, Makiyama A, Takegawa N, Sugiyama K, Hirano H, Ando T, Matsushima T, Chida A, Kashiwada T, Komoda M, Matsumoto T, Oda H, Yabusaki H, Kawakami H, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K; West Japan Oncology Group (WJOG). Komori A, et al. Among authors: furuta m. Gastric Cancer. 2024 Dec 31. doi: 10.1007/s10120-024-01579-2. Online ahead of print. Gastric Cancer. 2024. PMID: 39738793
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301).
Hashimoto K, Morinaga D, Asahina H, Ishidoya M, Kikuchi H, Yokouchi H, Harada T, Honjo O, Shigaki R, Takashina T, Fujita Y, Takahashi M, Kawai Y, Kida R, Ito K, Sukoh N, Takahashi A, Hommura F, Ohhara Y, Furuta M, Konno S, Hosomi Y, Oizumi S; Hokkaido Lung Cancer Clinical Study Group Trial. Hashimoto K, et al. Among authors: furuta m. JTO Clin Res Rep. 2024 Sep 7;5(11):100715. doi: 10.1016/j.jtocrr.2024.100715. eCollection 2024 Nov. JTO Clin Res Rep. 2024. PMID: 39403627 Free PMC article.
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small-cell lung cancer (NEJ056).
Furuta M, Horinouchi H, Yokota I, Yamaguchi T, Itoh S, Fukui T, Iwashima A, Sugisaka J, Miura Y, Tanaka H, Miyawaki T, Yokouchi H, Miura K, Saito R, Saito G, Kamoshida T, Uchinami Y, Kato T, Kobayashi K, Asahina H. Furuta M, et al. Cancer Sci. 2024 Nov;115(11):3705-3717. doi: 10.1111/cas.16340. Epub 2024 Sep 15. Cancer Sci. 2024. PMID: 39278260 Free PMC article.
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial.
Bressler SB, Barve A, Ganapathi PC, Beckmann K, Apte RS, Marcus DM, Baumane K, Agarwal S, Oleksy P, Reichstein DA, Patel SS, Ernest J, Dégi R, Gupta V, Kishino G, Kamei M, Loganathan S; INSIGHT Study Group. Bressler SB, et al. JAMA Ophthalmol. 2024 Oct 1;142(10):952-960. doi: 10.1001/jamaophthalmol.2024.3458. JAMA Ophthalmol. 2024. PMID: 39264599 Free PMC article. Clinical Trial.
746 results